These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 4281941

  • 1. Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
    Triantaphyllopoulos E.
    Thromb Diath Haemorrh Suppl; 1973; 56():91-112. PubMed ID: 4281941
    [No Abstract] [Full Text] [Related]

  • 2. The NH2-terminal amino acids of the fibrinogen degradation products. Implications for fibrinogen structure.
    Marder VJ, Budzynski AZ.
    Thromb Diath Haemorrh Suppl; 1973; 56():127-35. PubMed ID: 4281939
    [No Abstract] [Full Text] [Related]

  • 3. Degradation of fibrinogen by plasmin: biological effects of the non-dialysable fibrinogen derivatives.
    Triantaphyllopoulos DC, Chandra S.
    Thromb Diath Haemorrh Suppl; 1973; 56():113-26. PubMed ID: 4281938
    [No Abstract] [Full Text] [Related]

  • 4. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA, Fisher LM.
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4.
    Sherman LA, Mosesson MW, Sherry S.
    Biochemistry; 1969 Apr; 8(4):1515-23. PubMed ID: 4241001
    [No Abstract] [Full Text] [Related]

  • 6. [The effect of arginine on hydrolysis of fibrinogen by plasmin and mini-plasmin].
    Zolotareva EN, Grinenko TV, Skomorovskaia EV, Kudinov SA.
    Ukr Biokhim Zh (1978); 1992 Apr; 64(1):3-9. PubMed ID: 1387746
    [Abstract] [Full Text] [Related]

  • 7. Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen.
    Lahiri B, Shainoff JR.
    Biochim Biophys Acta; 1973 Mar 23; 303(1):161-70. PubMed ID: 4267201
    [No Abstract] [Full Text] [Related]

  • 8. The relationship between carbohydrate content and enzymic activity of yeast invertase.
    Waheed A, Shall S.
    Enzymologia; 1971 Nov 30; 41(5):291-303. PubMed ID: 4942843
    [No Abstract] [Full Text] [Related]

  • 9. The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally.
    Fletcher AP, Alkjaersig N, Fisher S, Sherry S.
    J Lab Clin Med; 1966 Nov 30; 68(5):780-802. PubMed ID: 4224270
    [No Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of N-terminal fragments obtained by plasmin digestion of human fibrinogen.
    Iwanaga S, Wallén P, Gröndahl NJ, Henschan A, Blombäck B.
    Biochim Biophys Acta; 1967 Dec 12; 147(3):606-9. PubMed ID: 4230076
    [No Abstract] [Full Text] [Related]

  • 11. Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer.
    Smith GF, Bang NU.
    Biochemistry; 1972 Aug 01; 11(16):2958-66. PubMed ID: 4261258
    [No Abstract] [Full Text] [Related]

  • 12. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA, Leonova VB, Khavkina LS.
    Izv Akad Nauk SSSR Biol; 1991 Aug 01; (3):334-42. PubMed ID: 1835465
    [Abstract] [Full Text] [Related]

  • 13. Picric acid soluble fragments liberated from fibrinogen by fibrinolysin.
    Triantaphyllopoulos E, Triantaphyllopoulos DC.
    Life Sci; 1968 Apr 15; 7(8):431-41. PubMed ID: 4231248
    [No Abstract] [Full Text] [Related]

  • 14. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU, Hansen MS, Smith GF, Latallo ZS, Chang ML, Mattler LE.
    Ser Haematol; 1973 Apr 15; 6(4):494-512. PubMed ID: 4277578
    [No Abstract] [Full Text] [Related]

  • 15. Isolation and characterization of the bovine parathyroid isohormones.
    Keutmann HT, Aurbach GD, Dawson BF, Niall HD, Deftos LJ, Potts JT.
    Biochemistry; 1971 Jul 06; 10(14):2779-87. PubMed ID: 5558700
    [No Abstract] [Full Text] [Related]

  • 16. [Fibrinogen and fibrin degradation products].
    Fujimaki M, Ikematsu S, Kato M.
    Rinsho Byori; 1973 Jan 06; 21(1):31-6. PubMed ID: 4267650
    [No Abstract] [Full Text] [Related]

  • 17. The structure of the fibrinogen degradation products.
    Marder VJ, Budzynski AZ.
    Prog Hemost Thromb; 1974 Jan 06; 2(0):141-74. PubMed ID: 4137300
    [No Abstract] [Full Text] [Related]

  • 18. The effect of fibrinogen degradation products on plasmin activity.
    Myśliwiec M, Arnesen H, Godal HC.
    Thromb Diath Haemorrh; 1973 Jun 28; 29(3):592-7. PubMed ID: 4271546
    [No Abstract] [Full Text] [Related]

  • 19. The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product.
    Applegate D, Steben LS, Hertzberg KM, Grieninger G.
    Blood; 2000 Apr 01; 95(7):2297-303. PubMed ID: 10733499
    [Abstract] [Full Text] [Related]

  • 20. Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis.
    Budzynski AZ, Marder VJ, Shainoff JR.
    J Biol Chem; 1974 Apr 10; 249(7):2294-302. PubMed ID: 4131967
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.